News for Moderna, Inc. (0A45.L)

Moderna, Inc.'s stock soars 16% amid patent win over Pfizer/BioNTech, while legal battles highlight mRNA challenges. Click for my MRNA update.

Moderna, Inc. (NASDAQ:MRNA) TD Cowen 45th Annual Health Care Conference March 5, 2025 9:10 AM ETCorporate ParticipantsStephen Hoge - PresidentConference...

BASEL, Switzerland and VANCOUVER, B.C. and WARMINSTER, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with

**media[555746]**

**media[555742]**

On February 28, 2025, Moderna Inc (MRNA) announced that the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization

ETF performance linked to top and bottom S&P 500 performers shows fund flows don't always follow stock trajectories.

The Donald Trump administration is contemplating the withdrawal of a $590 million contract previously granted to Moderna Inc. (NASDAQ: MRNA) by the Biden administration. This contract was intended for the production of a bird flu vaccine.

We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Moderna, Inc.

Moderna Inc (MRNA), a leader in mRNA medicine, announced on February 25, 2025, its participation in two upcoming investor conferences. The company will present

CAMBRIDGE, MA / ACCESS Newswire / February 25, 2025 / Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor confere

Long-established in the Biotechnology industry, Moderna Inc (MRNA) has enjoyed a stellar reputation. However, it has recently witnessed a daily loss of 4.59%, j

Robert F. Kennedy Jr.'s appointment as Secretary of Health and Human Services has sparked concerns over funding for the NIH.

Researchers at the Wuhan Institute of Virology in China said they discovered a new coronavirus in bats that enters cells using the same gateway as the

We recently published a list of Five Chinese Firms Dominate Friday’s Top 10 Gainers. In this article, we are going to take a look at where Moderna Inc.

Moderna Inc's robust mRNA platform technology continues to drive innovation and growth.Despite competitive pressures, Moderna Inc maintains a strong market pre

HKU5-CoV-2 virus in China: After Covid-19 and HMPV, a new bat coronavirus discovered in China has sparked concerns among health officials and has triggered another pandemic fear. The newly discovered virus, however, is yet to be detected in humans. As per the researchers, this virus enters cells via the same receptor used by the Coronavirus that caused Covid-19.

Stocks Analysis by Thomas Hughes covering: Moderna Inc. Read Thomas Hughes's latest article on Investing.com

Moderna Inc (MRNA) experienced a notable stock price increase of 8.28% recently, trading at approximately $35.72. This uptick in stock price reflects investor r